Exane Derivatives’s The Gap Inc GAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-243
Closed -$3.42K 1042
2022
Q1
$3.42K Hold
243
﹤0.01% 720
2021
Q4
$4.29K Buy
+243
New +$5.09K ﹤0.01% 626
2020
Q3
Sell
-155,054
Closed -$1.96M 776
2020
Q2
$1.96M Buy
155,054
+44,256
+40% +$399K 0.52% 56
2020
Q1
$780K Sell
110,798
-33,343
-23% -$495K 0.22% 91
2019
Q4
$2.58M Buy
144,141
+52,759
+58% +$898K 0.48% 69
2019
Q3
$1.59M Sell
91,382
-163,200
-64% -$2.9M 0.28% 78
2019
Q2
$4.57M Buy
254,582
+145,775
+134% +$3.27M 0.8% 21
2019
Q1
$2.85M Buy
108,807
+59,743
+122% +$1.53M 0.56% 57
2018
Q4
$1.26M Sell
49,064
-26,051
-35% -$696K 0.23% 106
2018
Q3
$2.17M Buy
75,115
+72,801
+3,146% +$2.18M 0.41% 72
2018
Q2
$76.8K Sell
2,314
-65,918
-97% -$2.03M 0.01% 359
2018
Q1
$2.11M Buy
68,232
+45,054
+194% +$1.47M 0.42% 64
2017
Q4
$789K Buy
23,178
+21,476
+1,262% +$640K 0.14% 125
2017
Q3
$50.3K Buy
1,702
+279
+20% +$6.86K 0.01% 307
2017
Q2
$31.3K Sell
1,423
-18,182
-93% -$433K 0.01% 344
2017
Q1
$476K Buy
19,605
+18,631
+1,913% +$445K 0.11% 136
2016
Q4
$21.9K Sell
974
-7,741
-89% -$199K ﹤0.01% 358
2016
Q3
$194K Sell
8,715
-4,385
-33% -$106K 0.03% 208
2016
Q2
$278K Sell
13,100
-11,640
-47% -$248K 0.05% 178
2016
Q1
$727K Sell
24,740
-23,649
-49% -$621K 0.1% 109
2015
Q4
$1.2M Buy
48,389
+36,702
+314% +$979K 0.16% 78
2015
Q3
$333K Buy
11,687
+3,420
+41% +$118K 0.04% 147
2015
Q2
$316K Sell
8,267
-2,607
-24% -$103K 0.03% 178
2015
Q1
$471K Sell
10,874
-6,474
-37% -$270K 0.05% 146
2014
Q4
$730K Buy
+17,348
New +$680K 0.1% 116

Other funds holding GAP

Exane Derivatives's GAP Position: Q2 2022 in Review

Exane Derivatives sold out of The Gap Inc (GAP) in Q2 2022, closing a stake of 243 shares — an estimated $3.42K sold.

Exane Derivatives first reported a position in GAP in Q4 2014 and held it in 25 quarters. The position peaked at $4.57M in Q2 2019. 357 funds tracked by Wall St. Rank hold GAP as of Q2 2022.

  • Exane Derivatives reported no remaining The Gap Inc position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 243 The Gap Inc shares in Q2 2022, an estimated $3.42K.
  • Exane Derivatives first reported a position in The Gap Inc in Q4 2014 and held it in 25 quarters.
  • Exane Derivatives's The Gap Inc position peaked at $4.57M in Q2 2019.
  • 357 funds tracked by Wall St. Rank held The Gap Inc as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.